...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The American Journal of Cardiology >Incidence and Prognosis of Pericarditis After ST-Elevation Myocardial Infarction (from the Acute Coronary Syndrome Israeli Survey 2000 to 2013 Registry Database)
【24h】

Incidence and Prognosis of Pericarditis After ST-Elevation Myocardial Infarction (from the Acute Coronary Syndrome Israeli Survey 2000 to 2013 Registry Database)

机译：ST升高心肌梗死后心包炎的发病率和预后（来自急性冠状动脉综合征以色列调查2000至2013年注册表数据库）

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

There are scarce contemporary data regarding the incidence and prognosis of early postmyocardial infarction pericarditis (PMIP). Thus, we retrospectively analyzed 6,282 patients with ST-segment elevation myocardial infarction (STEM!) enrolled with known PMIP status in the Acute Coronary Syndrome Israeli Survey 2000 to 2013 registry. The primary outcome was the composite of all-cause mortality, nonfatal myocardial infarction, cerebrovascular event, stent thrombosis, or revascularization. The secondary outcomes were mortality and length of stay during the acute hospitalization. Overall, 76 patients with STEMI had PMIP (1.2%). PMIP incidence gradually decreased from 170 per 10,000 in 2000 to 110 per 10,000 in 2013, respectively (35% reduction, p for trend = 0.035). Patients with PMIP were younger (median 58.0 vs 61.0; p = 0.045), had less hypertension, higher cardiac biomarkers, and more frequently reduced left ventricular ejection fraction (87.0% vs 67.0%; p = 0.001). Patients with PMIP had longer time to reperfusion (225 minutes vs 183 minutes; p = 0.016) and length of stay (7.0 vs 5.0 days; p 0.001). The composite end point occurred similarly in patients with and without PMIP (10.5% vs 13.2%, respectively). There was no significant difference in 30-day, 1-year, and 5-year survival. In conclusion, PMIP is a relatively rare complication of STEMI in the coronary reperfusion era, portends worse short-term but not long-term outcomes, and is associated with bigger infarct size. (C) 2017 Elsevier Inc. All rights reserved.
机译：关于早期后期梗死心包炎（PMIP）的发病率和预后存在稀缺的当代数据。因此，我们回顾性地分析了6,282名患者的ST段升高心肌梗死（Stem！），急性冠状动脉综合征以色列调查中的已知PMIP状态为2000至2013年登记处。主要结果是全因死亡率，非致死性心肌梗死，脑血管事件，支架血栓形成或血运重建的复合材料。急性住院期间的二次结果是死亡率和逗留时间。总体而言，76名患有PMIP（1.2％）。 PMIP发病率分别从2000年的170人逐渐降低至2013年每10,000天/每10,000天/每10,000人（减少35％，趋势= 0.035）。 PMIP患者较年轻（中位58.0 vs 61.0; p = 0.045），高血压，较高的心脏生物标志物，更常见地降低左心室喷射级分（87.0％vs 67.0％; p = 0.001）。 PMIP的患者的再灌注时间较长（225分钟与183分钟; P = 0.016）和保持长度（7.0 Vs 5.0天; P <0.001）。在没有PMIP的患者中，复合终点同样发生（分别为10.5％与13.2％）。 30天，1年和5年生存率没有显着差异。总之，PMIP是冠状动脉再灌注时代的STEMI的相对罕见的并发症，在短期内但不长期成果中的性能更差，并且与更大的梗塞大小有关。 （c）2017年Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号